Milky Mist IPO: GMP points to 15-19% debut

Subscription trend: Day 1 to Day 2 chatter

Milky Mist Dairy Food’s ₹1,553 crore mainboard IPO became a social-media talking point as subscription momentum improved quickly. Posts tracking live bid data said the issue was around 40% to 41% subscribed on the opening day. Other updates circulating later on Day 1 mentioned subscription levels closer to 70%, highlighting how fast the numbers were changing through the session. By Day 2, multiple trackers reported the IPO was fully subscribed. Retail and NII participation was repeatedly cited as the key driver of the demand. At the same time, several posts noted that institutional participation looked muted compared with the buzz among non-institutional bidders. The tone across threads was optimistic about listing-day pop, but more cautious on valuation for long-term holders. The most repeated takeaway was that demand strengthened, yet investors should separate subscription enthusiasm from eventual secondary-market performance.

IPO structure and key dates being shared

The IPO opened on August 11, 2026 and closes on August 13, 2026, as repeated across social posts and IPO trackers. The shares are proposed to list on both NSE and BSE, with a tentative listing date of August 18, 2026. The price band is ₹133 to ₹140 per share, with most listing-gain math done using the ₹140 upper band. Lot size is 107 shares, implying a minimum retail outlay of about ₹14,980 at the top band. Social summaries also broke down the issue size into a ₹1,428 crore fresh issue and a ₹125 crore offer for sale. Another widely shared detail was the post-issue market capitalisation estimate of ₹10,778 crore at ₹140 per share. Valuation metrics circulated alongside that number included an FY26 P/E estimate of about 84.86x to 85x at the upper band. The discussion around these facts shaped the core debate: potential listing gains versus a “fully valued” entry price.

Grey market premium: what it implies, not what it guarantees

Grey market premium, or GMP, was the most referenced datapoint in listing prediction posts about Milky Mist. Screenshots and updates showed GMP moving around ₹19, ₹20.5, ₹21, ₹22, ₹22.5, and even ₹26 at different times. At the ₹140 issue price, those GMP levels translate to an implied listing price near ₹159 to ₹166, depending on the reading used. Several sources framed this as a 14.6% to roughly 19% possible premium, with some posts rounding it to 15% to 20%. A recurring disclaimer in credible threads was that GMP-implied gains are not actual returns, because the stock was not yet listed. Some users also pointed out that GMP can change sharply close to listing day. Others treated the mid-teens range as a reasonable base case given the subscription trajectory. The practical consensus was to treat GMP as sentiment, not as a price target.

Listing price scenarios using the GMP range

Social posts frequently turned the GMP numbers into simple scenario tables for quick reference. At a GMP of ₹22, the implied listing price is around ₹162, which is roughly a 15.7% premium to ₹140. At a GMP of ₹22.5, some trackers put the implied listing price at ₹162.5, or about a 16% premium. Earlier updates at ₹20.5 implied roughly ₹160.5, or about a 14.6% premium. Higher prints such as ₹26 were presented as signalling close to a 19% listing gain. One tracker also circulated a model-based estimate of about +18.1%, with a stated range of +14.1% to +22.1% and “moderate” confidence at 64%. These figures were usually discussed as probabilistic, with many users stressing that final pricing depends on broader market conditions on listing day. The table below summarises the most shared numbers and their implied outcomes.

Valuation debate: premium pricing vs growth narrative

Alongside GMP, valuation was the second most debated topic across posts. Multiple summaries said the IPO looked “fully valued” at the upper band, even for investors who like the packaged food story. The most quoted valuation number was a post-IPO P/E of roughly 84.86x to about 85x at ₹140. Users framed this as the key reason to separate listing trade thinking from long-term holding decisions. Anand Rathi’s “Subscribe – Long Term” rating was shared widely, often with the caveat that the valuation is premium. That combination led to mixed interpretations, with some readers focusing on growth prospects and others focusing on the pricing. Some threads treated a mid-teens listing premium as already priced into the issue’s sentiment indicators. Others argued that strong retail demand can still deliver a positive debut even when valuation is rich. Overall, the valuation discussion stayed more cautious than the GMP discussion, and it anchored many “not a guaranteed win” comments.

Demand mix: retail and NII strength, institutions watched

Posts about subscription data repeatedly emphasised strong interest from retail and non-institutional investors. Day 2 being fully subscribed was attributed largely to these categories in multiple summaries. In parallel, several updates said institutional participation appeared muted, even as grey-market indicators stayed positive. This split in demand became a common talking point because it can influence how people interpret the quality of the book. Some users saw strong retail participation as supportive for listing-day liquidity and momentum. Others argued that muted institutional participation is worth monitoring when the valuation is high. The discussion did not suggest a single conclusion, but it did show investors looking beyond headline “fully subscribed” status. Many posters also reminded readers that allocation and listing-day supply can affect the debut even after strong subscription. The dominant takeaway was that the demand mix matters as much as the final subscription multiple.

Anchor allotment detail that got attention

A widely circulated BSE-based detail was that Milky Mist allotted 3.32 crore equity shares to anchor investors at ₹140 per share. Social users referenced the anchor price mostly to reinforce that the upper end of the band was the key benchmark. Some posts interpreted anchor participation as a stabilising factor, while others treated it as a standard step in mainboard IPOs. The anchor allotment was also used to explain why most GMP math was anchored to ₹140 rather than the lower band. A few commenters linked the anchor detail to the premium-valuation debate, suggesting that price acceptance is clear but not a guarantee of strong post-listing performance. The anchor allotment fact also appeared alongside the issue structure split of fresh issue and OFS. Overall, the anchor datapoint was treated as a credibility marker because it was tied to an exchange circular. It added context, but it did not settle the debate on whether the listing premium would hold.

How to read listing predictions and what can change

Most listing predictions in the social chatter were built from two inputs: GMP and subscription momentum. GMP-based implied prices such as ₹161 to ₹162.5 were often presented as “estimated listing price,” but several posts explicitly noted this is not a promised outcome. Because the IPO was set to list on August 18, users stressed that GMP can shift meaningfully between closing day and listing day. Some commenters also said broader market sentiment on the listing session can overwhelm pre-listing indicators. The model-style forecast shared by one tracker, +18.1% with a +14.1% to +22.1% range, was treated as a directional tool rather than a precise call. Investors discussing strategy often separated a short-term listing trade from a long-term view, especially given the ~85x P/E being cited. The most factual way to frame the prediction from the available data is a mid-teens implied premium range, contingent on GMP holding up. The most repeated caution was simple: implied gains from grey market and early demand do not equal realised returns after listing.